High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations
Moritz Fürstenau*, Yvonne J Thus, Sandra Robrecht, Clemens H M Mellink, Anne-Marie F van der Kevie-Kersemaekers, Julie Dubois, Julia von Tresckow, Michaela Patz, Michael Gregor, Patrick Thornton, Philipp B Staber, Tamar Tadmor, Mark-David Levin, Caspar da Cunha-Bang, Christof Schneider, Christian Bjørn Poulsen, Thomas Illmer, Björn Schöttker, Ann Janssens, Ilse ChristiansenThomas Noesslinger, Michael Baumann, Holger Hebart, Tobias Gaska, Josien Regelink, Ellen C Dompeling, Vesa Lindstrom, Gunnar Juliusson, Anouk Andrea Widmer, Jeroen S Goede, Neta Goldschmidt, Florian Simon, Nisha De Silva, Anna Maria Fink, Kirsten Fischer, Clemens-Martin Wendtner, Matthias Ritgen, Monika Brüggemann, Eugen Tausch, Marcel Spaargaren, Eric Eldering, Stephan Stilgenbauer, Carsten Utoft Niemann, Michael Hallek, Barbara Eichhorst, Karl-Anton Kreuzer, Arnon P Kater
Dyk ned i forskningsemnerne om 'High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations'. Sammen danner de et unikt fingeraftryk.